JP2004538381A - Cosmetic and anti-aging stockings or pantyhose impregnated with slowly released natural substances and methods of making the same - Google Patents
Cosmetic and anti-aging stockings or pantyhose impregnated with slowly released natural substances and methods of making the same Download PDFInfo
- Publication number
- JP2004538381A JP2004538381A JP2003519578A JP2003519578A JP2004538381A JP 2004538381 A JP2004538381 A JP 2004538381A JP 2003519578 A JP2003519578 A JP 2003519578A JP 2003519578 A JP2003519578 A JP 2003519578A JP 2004538381 A JP2004538381 A JP 2004538381A
- Authority
- JP
- Japan
- Prior art keywords
- pantyhose
- skin
- phospholipid
- stockings
- direct contact
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 15
- 239000005445 natural material Substances 0.000 title claims abstract description 13
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 12
- 239000002537 cosmetic Substances 0.000 title claims abstract description 12
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 22
- 239000004753 textile Substances 0.000 claims abstract description 18
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 230000003592 biomimetic effect Effects 0.000 claims abstract description 6
- 230000035515 penetration Effects 0.000 claims abstract description 6
- BYMMIQCVDHHYGG-UHFFFAOYSA-N Cl.OP(O)(O)=O Chemical compound Cl.OP(O)(O)=O BYMMIQCVDHHYGG-UHFFFAOYSA-N 0.000 claims abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 4
- 230000008595 infiltration Effects 0.000 claims abstract description 4
- 238000001764 infiltration Methods 0.000 claims abstract description 4
- 239000011734 sodium Substances 0.000 claims abstract description 4
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 4
- ISRLGZXSKRDKID-JXBDSQKUSA-N [3-bis[3-[dimethyl-[3-[[(9z,12z)-octadeca-9,12-dienoyl]amino]propyl]azaniumyl]-2-hydroxypropoxy]phosphoryloxy-2-hydroxypropyl]-dimethyl-[3-[[(9z,12z)-octadeca-9,12-dienoyl]amino]propyl]azanium;trichloride Chemical compound [Cl-].[Cl-].[Cl-].CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCC[N+](C)(C)CC(O)COP(=O)(OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCC\C=C/C\C=C/CCCCC)OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCC\C=C/C\C=C/CCCCC ISRLGZXSKRDKID-JXBDSQKUSA-N 0.000 claims abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 3
- 230000001580 bacterial effect Effects 0.000 claims abstract description 3
- 241000195493 Cryptophyta Species 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 24
- 210000000554 iris Anatomy 0.000 claims description 11
- -1 phospholipid compound Chemical class 0.000 claims description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- 235000015164 Iris germanica var. florentina Nutrition 0.000 claims description 6
- 244000050403 Iris x germanica Species 0.000 claims description 6
- 235000002971 Iris x germanica Nutrition 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 241001474374 Blennius Species 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003935 flavonoid Natural products 0.000 claims description 5
- 150000002215 flavonoids Chemical class 0.000 claims description 5
- 235000017173 flavonoids Nutrition 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000012190 activator Substances 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 3
- 238000006911 enzymatic reaction Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000011069 regeneration method Methods 0.000 claims description 3
- 241001116389 Aloe Species 0.000 claims description 2
- 235000011201 Ginkgo Nutrition 0.000 claims description 2
- 244000194101 Ginkgo biloba Species 0.000 claims description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 230000006750 UV protection Effects 0.000 claims description 2
- 235000011399 aloe vera Nutrition 0.000 claims description 2
- 239000005515 coenzyme Substances 0.000 claims description 2
- 238000004043 dyeing Methods 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- 235000009569 green tea Nutrition 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 241000199919 Phaeophyceae Species 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 241000512259 Ascophyllum nodosum Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000195628 Chlorophyta Species 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 229930002875 chlorophyll Natural products 0.000 description 4
- 235000019804 chlorophyll Nutrition 0.000 description 4
- 235000001916 dieting Nutrition 0.000 description 4
- 230000037228 dieting effect Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000206572 Rhodophyta Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical group C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- LZJRNLRASBVRRX-ZDUSSCGKSA-N Boldine Chemical compound CN1CCC2=CC(O)=C(OC)C3=C2[C@@H]1CC1=C3C=C(OC)C(O)=C1 LZJRNLRASBVRRX-ZDUSSCGKSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical class OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- KVVSCMOUFCNCGX-UHFFFAOYSA-N cardol Chemical compound CCCCCCCCCCCCCCCC1=CC(O)=CC(O)=C1 KVVSCMOUFCNCGX-UHFFFAOYSA-N 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- XHEFDIBZLJXQHF-UHFFFAOYSA-N fisetin Chemical compound C=1C(O)=CC=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 XHEFDIBZLJXQHF-UHFFFAOYSA-N 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical class OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- KYVJVURXKAZJRK-UHFFFAOYSA-N (+)-laurolitsine Natural products N1CCC2=CC(O)=C(OC)C3=C2C1CC1=C3C=C(OC)C(O)=C1 KYVJVURXKAZJRK-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JOLVYUIAMRUBRK-UHFFFAOYSA-N 11',12',14',15'-Tetradehydro(Z,Z-)-3-(8-Pentadecenyl)phenol Natural products OC1=CC=CC(CCCCCCCC=CCC=CCC=C)=C1 JOLVYUIAMRUBRK-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- YLKVIMNNMLKUGJ-UHFFFAOYSA-N 3-Delta8-pentadecenylphenol Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 208000023328 Basedow disease Diseases 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- JOLVYUIAMRUBRK-UTOQUPLUSA-N Cardanol Chemical compound OC1=CC=CC(CCCCCCC\C=C/C\C=C/CC=C)=C1 JOLVYUIAMRUBRK-UTOQUPLUSA-N 0.000 description 1
- FAYVLNWNMNHXGA-UHFFFAOYSA-N Cardanoldiene Natural products CCCC=CCC=CCCCCCCCC1=CC=CC(O)=C1 FAYVLNWNMNHXGA-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000195633 Dunaliella salina Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- FNUPUYFWZXZMIE-UHFFFAOYSA-N Fustin Natural products O1C2=CC(O)=CC=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000206581 Gracilaria Species 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 241001598113 Laminaria digitata Species 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000206754 Palmaria palmata Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 241000196251 Ulva arasakii Species 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- MHVCSDLBQKSFQV-HNNXBMFYSA-N boldine Natural products COc1cc2c(C[C@@H]3N(C)CCc4cc(C)c(OC)c2c34)cc1O MHVCSDLBQKSFQV-HNNXBMFYSA-N 0.000 description 1
- LZJRNLRASBVRRX-UHFFFAOYSA-N boldine trifluoroacetic acid salt Natural products CN1CCC2=CC(O)=C(OC)C3=C2C1CC1=C3C=C(OC)C(O)=C1 LZJRNLRASBVRRX-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- PTFIPECGHSYQNR-UHFFFAOYSA-N cardanol Natural products CCCCCCCCCCCCCCCC1=CC=CC(O)=C1 PTFIPECGHSYQNR-UHFFFAOYSA-N 0.000 description 1
- UFMJCOLGRWKUKO-UHFFFAOYSA-N cardol diene Natural products CCCC=CCC=CCCCCCCCC1=CC(O)=CC(O)=C1 UFMJCOLGRWKUKO-UHFFFAOYSA-N 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229930186222 escin Natural products 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000011990 fisetin Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- FNUPUYFWZXZMIE-HUUCEWRRSA-N fustin Chemical compound C1([C@@H]2[C@@H](C(C3=CC=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-HUUCEWRRSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 description 1
- 235000010209 hesperetin Nutrition 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 description 1
- 235000003248 hydroxytyrosol Nutrition 0.000 description 1
- 229940095066 hydroxytyrosol Drugs 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical class C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000011576 oleuropein Nutrition 0.000 description 1
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 150000003881 polyketide derivatives Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000012747 synergistic agent Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 description 1
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B11/00—Hosiery; Panti-hose
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B17/00—Selection of special materials for underwear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Materials Engineering (AREA)
- Cosmetics (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Medicines Containing Plant Substances (AREA)
- Socks And Pantyhose (AREA)
- Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Abstract
本発明は、ゆっくりと放出される天然物質を浸透させた美容術用およびアンチエイジングのストッキングあるいはパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターと、その製造方法を対象とする。バイオミメティックスのリン脂質成分の化合物は、次の通りである:A)浴の0.5%のリン脂質GLA(ボラージアミドプロピルPGジモニウムクロリドリン酸ナトリウム)、B)浴の1.5%のリン脂質PTC(コカミドプロピルPGジモニウムクロリドリン酸)。このリン脂質成分の化合物は、静電プロセスによって有効成分の「定着」あるいは浸透を促進させることを第一の働きとし、また細菌叢を制御する抗菌剤であることを第二の働きとする。これらの二つのリン脂質成分に、有効成分を含む天然物質が、最大合計2.10%で添加される。柔軟化および浸透の段階は、35℃と37℃の間に含まれる温度で約35分継続する。The present invention is directed to cosmetic and anti-aging stockings or pantyhose stocked with slow-release natural substances, or any textile supporter that comes into direct contact with the skin, and a method of making the same. The compounds of the phospholipid component of the biomimetic are as follows: A) 0.5% phospholipid GLA in the bath (sodium borageamidopropyl PG dimonium chloride phosphate), B) 1.5% phosphorous in the bath Lipid PTC (cocamidopropyl PG dimonium chloride phosphate). The first function of the compound of the phospholipid component is to promote "fixation" or penetration of the active ingredient by an electrostatic process, and the second function is to be an antibacterial agent for controlling a bacterial flora. To these two phospholipid components, natural substances containing the active ingredient are added up to a total of 2.10%. The softening and infiltration phase lasts about 35 minutes at a temperature comprised between 35 ° C and 37 ° C.
Description
【技術分野】
【0001】
本発明は、ゆっくりと放出される天然物質を浸透させた美容術用およびアンチエイジングのストッキングあるいはパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターと、その製造方法を対象とする。
【発明の開示】
【課題を解決するための手段】
【0002】
本発明によると、天然物質あるいは有効成分は、一つの実施態様によると、藻類およびアヤメ科植物のエキスの中に含まれている。
【0003】
藻類のエキスには、肌の組織に酸素を与え、肌の弾力性を増す働きがある。
【0004】
アヤメ科植物のエキスは、亜鉛およびビタミンAをもたらす。補酵素としての亜鉛は酵素反応に関わりを持ち、該酵素反応は、細胞の成長の間、および、癒合のプロセスを促進することで傷ついた組織を再生させる間に機能する。
【0005】
ビタミンAは、細胞の成長に不可欠な薬剤の一つであって、細胞の増殖を誘導する。
【0006】
藻類およびアヤメ科植物のエキスは、抗フリーラジカル作用をもつように相乗作用で作用する。
【0007】
藻類のエキスは、ウルバラクツカから抽出される。この藻類のエキスは、肌の弾力のある特性を保護し、強化する。
【0008】
本発明はまた、ストッキングあるいはパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターに、ゆっくりと放出される天然物質を浸透させることを可能にする製造方法も対象とする。
【0009】
本製造方法は、染色の段階の後、柔軟化のプロセスの時に、従来の柔軟化用の浴に、バイオミメティックスのリン脂質の化合物を混ぜることで作用することからなる。
【0010】
バイオミメティックスのリン脂質成分の化合物は、
A)浴の0.5%のリン脂質GLA(ボラージアミドプロピルPGジモニウムクロリドリン酸ナトリウム)、
B)浴の1.5%のリン脂質PTC(コカミドプロピルPGジモニウムクロリドリン酸)である。
【0011】
このリン脂質成分の化合物は、静電プロセスによって有効成分の「定着」あるいは浸透を促進することを第一の働きとし、また細菌叢を制御する抗菌剤であることを第二の働きとする。
【0012】
これらの二つのリン脂質成分に、有効成分を含む天然物質が、最大合計2.10%で添加される。柔軟化および浸透の段階は、35℃と37℃の間に含まれる温度で約35分継続する。
【0013】
柔軟化溶液の割合は、リン脂質成分、活性剤を含めて、10対1の割合でなければならない、すなわち、10kgの溶液に対して、1kgのパンティストッキングが浴の中を循環することになる。
【0014】
好ましい実施態様によると、有効成分あるいは天然物質は、
A)0.7%から最大1.00%の海藻、
B)0.3%から最大0.5%のウルバラクツカ、
C)0.3%から最大0.5%のジャーマンアイリス、
D)0.1%の香りのエッセンス、
最大合計で2.1%である。
【0015】
他の実施態様によると、有効成分は、
A)0.25%から最大0.35%のチョウセンニンジン、
B)0.25%から最大0.35%のイチョウ、
C)0.25%から最大0.35%のチドメグサ属、
D)0.25%から最大0.35%の緑茶、
E)0.50%から最大0.70%のアロエ(アロエベラ)、
最大合計で2.10%である。
[発明の概括的な説明]
【0016】
海藻およびフロラのエキスの特性、および、新世代のパンティストッキングあるいは肌と直接接触するあらゆる織物のサポーターへのそれらの影響。
【0017】
本発明は、パンティストッキングあるいは肌と直接接触するあらゆる織物のサポーターの特性にかかわるものであり、通常の利用の際に肌に接触して放出される、藻類およびアヤメ科植物のエキスの中に含まれる物質を利用することを可能にする。
【0018】
これらのストッキングおよびパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターは、藻類およびアヤメ科植物のエキスの中に含まれる物質によって得られる特性である、気持ちを和らげ、うっ血を除去し、潤いを与え、そしてとりわけ老化防止タイプの美容用の利点を提供する。それらはまた、相乗作用で、単独のあるいは他の成分と結びついたこれらの物質の効能、またそれらの製造方法に有効な物質の効能も享受する。
【0019】
藻類は、葉緑素をもつ葉状植物のグループ、すなわち、隠花植物または花のない植物の大きな科に属しており、一般的に色に関連して、緑色の藻類(緑藻類)、褐色の藻類(褐藻類)、紅色の藻類(紅藻類)、および藍色の藻類(ラン藻類)に分類される。
【0020】
該藻類は、ビタミン、無機塩に富み、抗酸化性で、汚染物質の除去を継続的に行い、促進することを可能にするものであり、それらがヨウ素を含有しているおかげで代謝を活発にする。該藻類は、身体全体の外観を改善することに貢献する。
【0021】
藻類は、産業界および農業界において、多くの形で利用されている。さらに、それらは、栄養失調に起因したおよび/あるいは代謝のアンバランスに結びついた特定の疾患の治療において、栄養の役割を果たしている。ヨウ素が多く含まれていることから、特定の褐藻類(コンブ属およびヒバマタ属)は、甲状腺種の治療およびバセドー病において17世紀に既に利用されていた。
【0022】
これらの様々な生理学の効果によって、
−ヨウ素の代謝の障害、
−器質的な欠陥、
−ビタミンあるいはオリゴ成分の不足、
−くる病、肥満症、
−リウマチ性体質、動脈硬化の体質、
−様々な伝染病、
−腸管の寄生虫症、
−尿道の特定の障害、
−胃炎、大腸炎、
−循環器系障害、
のような病気および症候群における藻類の処方が説明される。
【0023】
栄養の特性のほかに、藻類は美容用のケアにおいてもまた、特に気持ちを和らげ、皮膚を軟らかくし、そして清めるというそれらの性質のために、利用が増大している。
【0024】
以下、これらが非常に頻繁に利用される特定の藻類、および、それらに認められている機能である。
【0025】
呼称:ウルバラクツカ、または海のレタス、
産地:地中海、
主な成分および適応:ビタミンA、肌の保護のためおよびアクネの治療用。
【0026】
呼称:ヒバマタ、または海のコナラ、
産地:大西洋沿岸、
主な成分および適応:ミネラル、とりわけヨウ素(代謝を刺激)、アルギン酸塩(外用のモイスチャライザー)、プロテイン、ベータカロチン、グループEのビタミン(アンチエイジング)で、痩せるためのダイエット用、フレグモーネの美的ではない影響に抗するため、皮膚の老化に対するクリーム状およびパック状。
【0027】
呼称:ケルプ、
産地:ノルウェー、
主な成分および適応:カルシウム、カリウム、ビタミン、ミネラル、および粘滑剤であって、局所用のモイスチャライザーとして、また痩せるためのダイエットにおけるもの。
【0028】
呼称:コンブ目、またはコンブ、
産地:日本、
主な成分および適応:ミネラル、ヨウ素、鉄、カルシウム、およびマグネシウムであって、解毒作用があり、皮膚の不純物の減少および肌の老化の減速を伴う。
【0029】
呼称:ワカメ、
産地:日本、
主な成分および適応:マグネシウム、鉄、カルシウム、およびビタミンA,B,Cであって、肌および皮膚の付属器官である髪および爪の状態を最適化する。
【0030】
呼称:アラメ、
産地:日本、
主な成分および適応:ヨウ素およびカルシウムであって、痩せるためのダイエットおよびフェイスケア用に適する。
【0031】
呼称:ノリ、
産地:朝鮮、
主な成分および適応:プロテイン、ベータカロチン、およびヨウ素で、肌の弾力性および輝きを与える。
【0032】
呼称:ダルス、
産地:北ヨーロッパ、
主な成分および適応:鉄およびヨウ素であって、痩せるためのダイエットにおいて有効である。
【0033】
呼称:スピルリナ、
産地:中国、葉緑素およびビタミンのある淡水の鏡のような水面、
主な成分および適応:ヨウ素がなく、解毒作用、および有機体の浄化作用があり、肌に輝きを与え、痩せるためのダイエットに有効である。
【0034】
呼称:クラマス、
産地:同名の湖、オレゴン州(アメリカ合衆国)、
主な成分および適応:アミノ酸およびプロテイン、酵素、葉緑素、ベータカロチン、無機塩、痩せるためのダイエット用、皮膚の老化を予防する。
【0035】
呼称:デュナリエラ・サリナ、
産地:北アメリカ、オーストラリア、および死海、
主な成分および適応:皮膚の保護物、老化防止物としてのベータカロチンの高い濃度により、健康で若々しい外観の肌を保つことが可能になり、日焼けのケアの場合に保護する働きを伴う。
【0036】
呼称:クロレラ、
産地:日本、
主な成分および適応:プロテイン、葉緑素、ミネラル、およびビタミンであって、細胞の除去および再生を促進し、痩せるためのダイエットにおいて、人体にバランスを取り戻させ、また場合によっては起こり得る特定の栄養失調を補うために有効である。
【0037】
美容術での藻類の利用は実際、一定期間の間に活発になった。皮膚科学の特性は、一連の作用物質から生じており、該作用物質の中には、例えばプロビタミンAおよびDおよびビタミンCである抗酸化ビタミン、水分を補給し、粘液状である特殊なバイオポリマー、生物学的に有効な様々な二次代謝物質がある。
【0038】
藻類を含む現在利用されている美容製品は、クレンジングミルク、強壮剤、モイスチャークリーム、デオドラント、手用、顔用、および体用のクリーム、性器用クレンジング、シャンプー、並びに、入浴用の特殊な製品、フレグモーネ、線状皮膚萎縮、アクネの問題に抗するのに有効な調合薬を含み、そして皮膚の外観を改善するのに貢献する。
【0039】
タラソテラピーでのフレグモーネに抗する治療は、様々なタイプの海藻と組み合わされた、典型的なオリゴ成分の豊富な海水を利用する。該治療は、特殊な美容用の調合薬を用いて行うことができ、また場合によっては、そのまま、またはエキスの形での海藻を主成分とする調合薬の局部塗布によって行われるが、それらは、泥、パック、および他のその場で調合される局所塗布のようなものである。
【0040】
現在利用されている美容法の不都合は、塗布の時間および皮膚の表面との接触に関連しており、必然的に、日中の間に限定された時間に因るものである。
【0041】
本発明はとりわけ、ストッキングあるいはパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターのようなサポーターに、有効物質を浸透させるということに存する。
【0042】
ストッキングおよびパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターは、藻類およびアヤメ科植物を主成分とする我々の調合薬の美容効果を、一定期間に渡って引き延ばすのに理想的なサポーターである、というのも、それらは恒常的に肌と接触しており、有効物質の長く段階的な放出によって、それらの有益な特性を保証するからである。このことは、本産業分野における新機軸となる。
【0043】
実際、様々なタイプの藻類およびアヤメ科植物の物質は、ストッキングあるいはパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターの繊維の表面および内側に、吸収し、堆積するために利用される。
【0044】
様々な種類の藻類により、特に興味深い塗布が可能になる。例えば:
【0045】
褐藻類:ヒバマタ、エゾイシゲ、アスコフィルム、ヒマンタリア、ラミナリア、ホンダワラ種。
【0046】
紅藻類:ツノマタ、イボノリあるいはスギノリ、ダルス、アマノリ、イギス、およびオゴノリ。
【0047】
緑藻類:ウルバ、アオノリ、およびミル。
【0048】
次の種々の藻類も挙げられる:アスコフィルム・ノドサム、ペルベチア・カナリクラータ、アオノリ、パルマリア・パルマータ、タマハハキモク、セラミウム・ルブラム、グラシラリア・ウェルコサ、ウルバラクツカ、ラミナリア・デジタータ、ミル。
【0049】
全ての藻類が、抗フリーラジカルおよび老化防止の重要な作用を有している。特に、褐藻類、中でもヒバマタである。
【0050】
好ましい実施態様によると、選ばれる藻類はウルバラクツカであって、これはキャベツと同じ量のビタミンAおよびオレンジと同じ量のビタミンC、またさらにグループBのビタミンの広いスペクトルを含む。ヨウ素、臭素、Ca,Mg,およびK、Mnといった無機塩およびオリゴ成分の多い含有物が再び見出されるが、該含有物によってそれらの抗アレルギー効果のいくつかの説明がつく。
【0051】
ウルバラクツカは、さらに、アミノ酸(プロリン、グリシン、リジン)が豊富であり、これらは皮膚の弾力性の維持において重要な役割を果たすものである。
【0052】
ウルバラクツカの組成の完全なスペクトルが、表1に記述されている。
【0053】
【表1】
【0054】
この発明の枠組みで利用される藻類のエキスは、超臨界流体の利用も含め、液相での抽出という慣習的な方法によって準備される。
【0055】
水を含んだ手段による抽出については、それは特殊な緩衝液によって制御されるpHで行われる。抽出は複数の極性溶媒の利用によっても行われるが、該複数の溶媒は合わせて、あるいは、水を含んだ手段と組み合わせて利用される。
【0056】
製造の最終段階は、エキスの脱水にあり、これは真空下での濃縮によって、あるいは逆浸透法によって、あるいはまたクロマトグラフィーあるいは限外濾過による濃縮および精製によって行われる。特徴的な場合において、藻類のエキスから分離される特定の物質は、化学合成によって得られるが、該物質は例えば、フコーリ、ポリフコーリ、ジフロレトーリ、ポリフロレトーリ、ビフアローリ、ポリフアローリ、およびフロレトーリであって、これらは、優れた抗フリーラジカル作用を有する。したがって、この説明において、「藻類のエキス」という用語は、概して、これらのエキスから分離される物質あるいは化学合成によって得られる物質を記述するために使用される。
【0057】
利用される藻類のエキスは、ストッキングおよびパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーターに美容の作用を付与するために、アヤメ科植物のエキスと組み合わされている。
【0058】
アヤメ科植物の中で、ジャーマンアイリスが特に好ましく、該ジャーマンアイリスは、抗酸化作用の高いポリフェノール、フラボノイド、およびアントシアンに富み、したがって強い抗酸化作用を伴う。本発明の対象である、製品の老化防止の特性を発揮させる目的において、藻類のエキスに含まれる物質は、一つあるいは複数の酸化防止剤と組み合わされている。
【0059】
われわれの目的に適合した酸化防止剤は、非網羅的な仕方で、種子、葉、花、そして果実および植物の皮の中に含まれる酸化防止剤を含み、また、天然の土地あるいは人工産の相当するものからの採掘に由来するものであってよい。
【0060】
代表的な酸化防止剤は、特定のアミノ酸(例:ヒスチジンおよびバリン)、フラボノイド(例:アルマデンドリン、モリン、クエルシトリン、ヘスペレチン、ナリンゲニン、ケンフェロール、アピゲニン、ルテオリン、フィセチン、フスチン、ルチン、ミリセチン)、アントシアン(例:ペラルゴニジン、シアニジン、デルフィニジン)、カテキン(例:カテキン、エピカテキン,ガロカテキン,プロアントシアノシド)、カロチノイドおよびレチノイド(カロチンの異性体、リコピン、キサンチン、レチノール、カタキサンチン、トコフェロール(例:アルファ−トコフェロール、ベータ−トコフェロールおよびガンマ−トコフェロール)、タンニン(例:没食子酸、没食子酸プロピルおよび没食子酸エステル、タンニン酸)、リン脂質(例:卵および大豆のレシチン)、L−アスコルビン酸およびエステル、アルファ−ヒドロキシ酸(例:乳酸、クエン酸、L−酒石酸)、モナスカスの紅いポリケチド、落花生および米の物質(例:カルダノール、カルドール、アナカルド酸、オリザノール、カシューナッツ油)、チオジプロピオン酸およびラウリンエステル(DLTBP)、アルファ−リポ酸、ノルジヒドログアヤレト酸(NDGA)、グアヤコール、ヒドロキシチロソール、およびオリーブオイルエステル(例:オレウロピン、ベルバスコシド)、香辛料およびハーブの他のフェノール(例:マンネンロウ、クローブ、トウガラシ、シナモン、ショウガ、パプリカ(TBHQ)、柑橘類の油、トリヒドロキシブチロフェノン(THBP)、BHT、およびBHA)、マクルリン、エトキシキン、エラグ酸、ムシジン、ボルジンであるが、また、それらの対応するグルコシド、エステルおよびエーテル、およびそれらの化合物もある。
【0061】
特に好ましい酸化防止剤の中で、没食子酸およびそれらの誘導体、アスコルビン酸およびそれらの誘導体を、さらにまた、植物エキスの中に含まれる、あるいは精製された形のフラボノイドも挙げられる。
【0062】
補助および/または相乗作用の働きのある他のタイプの有効成分は、さらに本発明において利用される。
【0063】
これらのカテゴリーに限られないにも関わらず、一般的な例は、しわ防止剤および抗炎剤を含む。
【0064】
抗炎剤の例の中には、カンゾウの誘導体、フラボノイド、アルファ−ビサボロール、マンネンロウ、アズレン、アシアチコシド、ルスコゲニン、エシン、ベツリン酸、およびそれらの誘導体が見られる。
【0065】
しわ防止剤の例は、レチノール、トコフェノール、サリチル酸塩、およびそれらの誘導体である。
【0066】
本発明の対象である、パンティストッキングあるいは肌と直接接触するあらゆる織物のサポーターの製造のために、これらの方法のうちの複数を利用することができる。
【0067】
有効成分(相乗作用のある藻類および薬剤)を含む重合ゲルあるいは樹脂を用いた定着、マイクロカプセルの付着、浸透、例えば適切な界面活性剤を用いて行われる表面の沈殿あるいは吸収。
【0068】
陽イオン界面活性剤、非イオン界面活性剤、陰イオン界面活性剤、両性界面活性剤、およびそれらの化合物も、有効に利用されている。
【0069】
界面活性剤の中で、次が挙げられる:
【0070】
非イオン界面活性剤:アルコールのアルコキシラートおよび脂肪酸あるいはソルビタン脂肪酸、ポリオキシプロピレンおよびポリオキシエチレン、アルキルポリグリコシド;陰イオン界面活性剤:脂肪酸石けん、ラウリル硫酸ナトリウムあるいはラリウルエーテル硫酸塩、アルキルベンゼンスルホナート、モノおよび/あるいはジアルキルリン酸塩、および同種物;
【0071】
両性界面活性剤:ジアルキルアンミン酸化物、様々なタイプのベタイン、リン脂質、および天然セラミド。
【0072】
界面活性剤の中では、陽イオンを帯びたグリセロ−ホスホコリン性の物質であるバイオミメティックスのリン脂質(Monaの製品、アメリカ合衆国)が好ましい。
【0073】
さらに、本発明の対象である製品は、様々な種の微生物に対する抗繁殖作用をもつ物質を用いて処理されるが、これは例えば、p−ヒドロキシ安息香酸の外のアルキル、イダントイン(idantoine)、パラベン、イミダゾリジニルウレア、デヒドロ酢酸ナトリウム、ベンジルアルコール、および四元素からなるアンモニウムイオンの成分の範囲を用い、さらにヨウ素および水銀を含んだ成分のような無機あるいは混合の物質を用いる。
【0074】
太陽フィルターを、柔軟化浴および活性剤、例えばPABA、ベンゾフェノンの誘導体、およびシナメートに、所望の紫外線保護の程度に応じた量で混ぜてもよい。
【0075】
類型論の例、ストッキングおよびパンティストッキングおよび、ウルバラクツカのエキス、緑藻類のエキス、およびジャーマンアイリスのエキスを用いた組成。
【発明を実施するための最良の形態】
【0076】
添付の図面は、例として与えられており、本発明を制限するものではない。該図面は、本発明の実施態様を示すのみであり、また発明を容易に理解できるようにするものである。
【0077】
図1は、概略図であって、ストッキングあるいはパンティストッキングあるいは肌と直接接触するあらゆる織物のサポーターを定着させ、あるいは浸透させることを可能にする循環路を明らかにしている。
【0078】
この図において、容器1は、リン脂質(リン脂質GLA(ボラージアミドプロピルPGジモニウムクロリドリン酸ナトリウム)およびリン脂質PTC(コカミドプロピルPGジモニウムクロリドリン酸))、有効成分、および柔軟化剤を全て受け入れ、配管2を通して、より大きい容器3につながっており、該容器は、ストッキングあるいはパンティストッキング、あるいは肌と直接接触するあらゆる織物のサポーター4を含む定着用および浸透用の容器である。格子5は、その上部において前記容器3を閉める。配管6は、容器3を容器1につなぐ。循環路はしたがって、連続する流れを伴う、閉鎖された循環路である。
【図面の簡単な説明】
【0079】
【図1】ストッキングあるいはパンティストッキングあるいは肌と直接接触するあらゆる織物のサポーターを定着させ、あるいは浸透させることを可能にする循環路を明らかにしている概略図である。
【符号の説明】
【0080】
1 容器
2 配管
3 定着用および浸透用の容器
4 ストッキングあるいはパンティストッキングあるいは肌と直接接触するあらゆる織物のサポーター
5 格子
6 配管【Technical field】
[0001]
The present invention is directed to cosmetic and anti-ageing stockings or pantyhose stockings impregnated with slow-release natural substances, or any textile supporter that comes into direct contact with the skin, and a method of making the same.
DISCLOSURE OF THE INVENTION
[Means for Solving the Problems]
[0002]
According to the invention, the natural substance or active ingredient is, according to one embodiment, contained in algae and iris extracts.
[0003]
Algae extracts have the function of providing oxygen to skin tissues and increasing skin elasticity.
[0004]
Iridaceous plant extracts provide zinc and vitamin A. Zinc as a coenzyme is involved in enzymatic reactions, which function during cell growth and during regeneration of damaged tissue by promoting the process of healing.
[0005]
Vitamin A is one of the essential drugs for cell growth and induces cell proliferation.
[0006]
Algae and Iridaceae extracts act synergistically to have an anti-free radical effect.
[0007]
Algae extract is extracted from Ulbaractuka. This algal extract protects and enhances the elastic properties of the skin.
[0008]
The invention is also directed to a method of manufacture that allows the slow release of natural substances to penetrate the supporter of stockings or pantyhose, or any textile that is in direct contact with the skin.
[0009]
The production method consists in acting after mixing the biomimetic phospholipid compound into a conventional softening bath during the softening process after the dyeing stage.
[0010]
The compound of the phospholipid component of biomimetic is
A) 0.5% phospholipid GLA (sodium borageamidopropyl PG dimonium chloride phosphate) in the bath,
B) 1.5% of the bath is a phospholipid PTC (cocamidopropyl PG dimonium chloride phosphoric acid).
[0011]
The first function of the compound of the phospholipid component is to promote "fixation" or penetration of the active ingredient by an electrostatic process, and the second function is to be an antibacterial agent for controlling a bacterial flora.
[0012]
To these two phospholipid components, a natural substance containing the active ingredient is added up to a total of 2.10%. The softening and infiltration phase lasts about 35 minutes at a temperature comprised between 35 and 37 ° C.
[0013]
The proportion of the softening solution, including the phospholipid component, the activator, must be 10 to 1, ie 1 kg of pantyhose will circulate in the bath for 10 kg of solution .
[0014]
According to a preferred embodiment, the active ingredient or natural substance is
A) 0.7% up to 1.00% seaweed;
B) 0.3% to a maximum of 0.5% of Urbaraktsuka,
C) 0.3% up to 0.5% German iris,
D) 0.1% fragrance essence,
The maximum total is 2.1%.
[0015]
According to another embodiment, the active ingredient is
A) 0.25% up to 0.35% ginseng;
B) Ginkgo from 0.25% up to 0.35%,
C) from 0.25% to a maximum of 0.35% of the genus Phytophthora,
D) 0.25% up to 0.35% green tea,
E) 0.50% up to 0.70% Aloe (Aloe Vera),
The maximum total is 2.10%.
[General description of the invention]
[0016]
Properties of seaweed and flora extracts and their impact on new generations of pantyhose or supporters of any textiles that come into direct contact with the skin.
[0017]
The present invention relates to the properties of supporters of pantyhose or any textile that comes into direct contact with the skin, and is included in extracts of algae and irises released on contact with the skin during normal use. To make use of the materials to be used.
[0018]
Supporters of these stockings and pantyhose, or any fabric that comes into direct contact with the skin, will relieve feelings, remove congestion, and moisturize the properties provided by the substances contained in algae and iris extracts. Gives and provides cosmetic benefits, especially of the anti-aging type. They also enjoy the effect of these substances, either synergistically, alone or in combination with other ingredients, as well as those that are effective in their method of manufacture.
[0019]
Algae belong to a group of chlorophyll-bearing foliate plants, that is, a large family of cryptic or flowerless plants, generally associated with color, green algae (green algae), brown algae (brown algae). ), Red algae (red algae), and blue algae (cyanobacteria).
[0020]
The algae are rich in vitamins and inorganic salts, are antioxidant and allow for the continuous and accelerated removal of pollutants, and are active in metabolism thanks to their iodine content To The algae contribute to improving the appearance of the whole body.
[0021]
Algae are used in many forms in the industrial and agricultural industries. In addition, they play a nutritional role in the treatment of certain diseases caused by malnutrition and / or linked to metabolic imbalance. Due to the high content of iodine, certain brown algae (genus kelp and genus genus) were already utilized in the treatment of thyroid species and in the 17th century in Basedow's disease.
[0022]
Due to these various physiological effects,
-Disorders of iodine metabolism,
-Organic defects,
-Lack of vitamins or oligo ingredients,
-Rickets, obesity,
-Rheumatic constitution, atherosclerotic constitution,
-Various infectious diseases,
Intestinal parasitosis,
-Certain disorders of the urethra,
-Gastritis, colitis,
-Cardiovascular disorders,
Algal prescriptions in diseases and syndromes such as are described.
[0023]
In addition to their nutritional properties, algae are also increasingly being used in cosmetic care, especially because of their properties of soothing, softening and purifying the skin.
[0024]
The following are specific algae that are very frequently used and their recognized functions.
[0025]
Name: Urbaraktsuka or sea lettuce,
Origin: Mediterranean,
Main ingredients and indications: Vitamin A, for skin protection and for acne treatment.
[0026]
Name: Hiba Mata, or Sea Quercus,
Origin: Atlantic coast,
Main Ingredients and Indications: Minerals, especially iodine (stimulates metabolism), alginate (topical moisturizer), protein, beta-carotene, vitamins of group E (anti-aging), for dieting to lose weight, aesthetics of Fragmone Creamy and packed on skin aging to resist no effects.
[0027]
Name: Kelp,
Origin: Norway,
Main ingredients and indications: calcium, potassium, vitamins, minerals and demulcents, as topical moisturizers and in diets for weight loss.
[0028]
Name: kelp eyes or kelp,
Origin: Japan,
Main ingredients and indications: minerals, iodine, iron, calcium, and magnesium, which are detoxifying, with reduced skin impurities and slowed skin aging.
[0029]
Name: Wakame,
Origin: Japan,
Main ingredients and indications: magnesium, iron, calcium and vitamins A, B, C, which optimize the condition of the hair and nails, the skin and its appendages to the skin.
[0030]
Name: Alame,
Origin: Japan,
Main ingredients and indications: iodine and calcium, suitable for weight loss diet and face care.
[0031]
Name: Nori,
Origin: Korea,
Main ingredients and indications: Protein, beta-carotene, and iodine, give skin elasticity and shine.
[0032]
Name: Daruss,
Origin: Northern Europe,
Main Ingredients and Indications: Iron and iodine, effective in dieting to lose weight.
[0033]
Name: Spirulina,
Origin: China, freshwater mirror-like water surface with chlorophyll and vitamins
Main Ingredients and Indications: Free of iodine, detoxifying and purifying organisms, shine on skin, effective for dieting to lose weight.
[0034]
Name: Klamath,
Origin: Lake of the same name, Oregon (United States),
Main ingredients and indications: amino acids and proteins, enzymes, chlorophyll, beta-carotene, inorganic salts, for dieting to lose weight, prevent skin aging.
[0035]
Name: Dunaliella Salina,
Origin: North America, Australia, and the Dead Sea,
Main ingredients and indications: High levels of beta-carotene as a skin protector and an anti-aging agent allow to keep the skin looking healthy and youthful, with protective action in case of sunburn care .
[0036]
Name: Chlorella,
Origin: Japan,
Main Ingredients and Indications: Proteins, chlorophylls, minerals, and vitamins that help the human body rebalance and, in some cases, specific malnutrition in a diet to promote cell removal and regeneration and to lose weight It is effective to make up for.
[0037]
The use of algae in cosmetology has in fact become active over a period of time. Dermatological properties derive from a series of active substances, among which are antioxidant vitamins, for example provitamins A and D and vitamin C, special bioactive substances that are hydrated and mucus-like. There are polymers, various secondary metabolites that are biologically effective.
[0038]
Currently used beauty products, including algae, include cleansing milk, tonics, moisturizing creams, deodorants, hand, facial, and body creams, genital cleansing, shampoos, and special products for bathing, Contains preparations that are effective in combating Fregmone, linear skin atrophy, acne problems, and contributes to improving skin appearance.
[0039]
Thalassotherapy treatment against Fregmone utilizes typical oligo-rich seawater combined with various types of seaweed. The treatment can be carried out using special cosmetic preparations, and in some cases, as such or by topical application of seaweed-based preparations in the form of extracts, , Mud, packs, and other topical formulations that are dispensed in place.
[0040]
The disadvantages of currently used cosmetic methods are related to the time of application and the contact with the surface of the skin, which is necessarily due to the limited time during the day.
[0041]
The invention consists, inter alia, in penetrating the active substance into supporters, such as stockings or pantyhose, or any textile supporter that comes into direct contact with the skin.
[0042]
Stocking and pantyhose, or any textile supporter that comes into direct contact with the skin, is an ideal supporter for extending the beauty benefits of our algae and iris-based pharmaceuticals over time Since they are in constant contact with the skin and ensure their beneficial properties by a long, gradual release of the active substance. This is a revolution in the industry.
[0043]
Indeed, various types of algae and iris materials are used to absorb and deposit on the surface and inside the fibers of stockings or pantyhose, or any textile supporter in direct contact with the skin.
[0044]
Various types of algae allow for particularly interesting applications. For example:
[0045]
Brown algae: Hibarata, Ezoishige, Ascofilm, Himantaria, Laminaria, Hondawara species.
[0046]
Red algae: Tunomata, Ibonori or Suginori, Darus, Amanori, Igisu, and Ogonori.
[0047]
Green algae: Urba, Aonori, and Mill.
[0048]
Also included are various algae: Ascofilm Nodosam, Pervecia Canariculata, Aonori, Palmaria Palmata, Tamahakimokum, Cerium Lubram, Gracilaria Welkosa, Urbaraktuka, Laminaria Digitata, Mill.
[0049]
All algae have important antifree radical and antiaging effects. In particular, brown algae, especially Hibamata.
[0050]
According to a preferred embodiment, the algae chosen is Wolbarack stag, which contains the same amount of vitamin A as cabbage and the same amount of vitamin C as orange, and also a broad spectrum of group B vitamins. Inorganic salts, such as iodine, bromine, Ca, Mg, and K, Mn, are again found to be rich in oligo- and oligo components, which explain some of their antiallergic effects.
[0051]
Urbalactuka is also rich in amino acids (proline, glycine, lysine), which play an important role in maintaining skin elasticity.
[0052]
The complete spectrum of the composition of Wolbarakutka is set forth in Table 1.
[0053]
[Table 1]
[0054]
The algae extract utilized in the framework of this invention, including the use of supercritical fluids, is prepared by conventional methods of extraction in the liquid phase.
[0055]
For extraction by means containing water, it is performed at a pH controlled by a special buffer. The extraction can also be performed by using a plurality of polar solvents, which are used together or in combination with a means containing water.
[0056]
The final stage of production consists in the dehydration of the extract, which is carried out by concentration under vacuum or by reverse osmosis, or alternatively by concentration and purification by chromatography or ultrafiltration. In a characteristic case, the specific substance separated from the algal extract is obtained by chemical synthesis, for example, fucori, polyfucoli, difloretori, polyfloretoli, bihuaroli, polypharyoli, and floretori, which are Has excellent anti-free radical action. Thus, in this description, the term "algal extracts" is generally used to describe substances separated from these extracts or obtained by chemical synthesis.
[0057]
The algae extract utilized is combined with an iris extract to impart a cosmetic effect to stockings and pantyhose, or any textile supporter that is in direct contact with the skin.
[0058]
Among the irises, German irises are particularly preferred, which are rich in polyphenols, flavonoids and anthocyans which have a high antioxidant activity and are therefore associated with a strong antioxidant effect. The substances contained in the algal extract are combined with one or more antioxidants for the purpose of exerting the anti-aging properties of the product, which is the subject of the present invention.
[0059]
Antioxidants suitable for our purposes include, in a non-exhaustive manner, antioxidants contained in seeds, leaves, flowers, and fruits and plant skins, as well as natural or artificial sources. It may come from mining from the equivalent.
[0060]
Representative antioxidants include certain amino acids (eg, histidine and valine), flavonoids (eg, almadendrine, morin, quercitrin, hesperetin, naringenin, kaempferol, apigenin, luteolin, fisetin, fustin, rutin, myricetin) , Anthocyans (eg, pelargonidin, cyanidin, delphinidin), catechins (eg, catechin, epicatechin, gallocatechin, proanthocyanoside), carotenoids and retinoids (isomer of carotene, lycopene, xanthine, retinol, cataxanthin, tocopherol (examples) : Alpha-tocopherol, beta-tocopherol and gamma-tocopherol), tannins (eg, gallic acid, propyl gallate and gallate, tannic acid), phospholipids ( : Lecithin of eggs and soybeans), L-ascorbic acid and esters, alpha-hydroxy acids (eg, lactic acid, citric acid, L-tartaric acid), monascus red polyketide, peanut and rice substances (eg, cardanol, cardol, anacardo) Acid, oryzanol, cashew nut oil), thiodipropionic acid and lauric ester (DLTBP), alpha-lipoic acid, nordihydroguaiaretic acid (NDGA), guaiacol, hydroxytyrosol, and olive oil esters (eg, oleuropein, verbascoside) ), Spices and other phenols of herbs (eg Mannen wax, cloves, pepper, cinnamon, ginger, paprika (TBHQ), citrus oil, trihydroxybutyrophenone (THBP), BHT, and BHA), maccle Emissions, ethoxyquin, ellagic acid, Mushijin, is a boldine, and there their corresponding glucoside, esters and ethers, and also their compounds.
[0061]
Particularly preferred antioxidants include gallic acid and their derivatives, ascorbic acid and their derivatives, and also flavonoids which are contained in plant extracts or in purified form.
[0062]
Other types of active ingredients which act as auxiliary and / or synergistic agents are further utilized in the present invention.
[0063]
Although not limited to these categories, common examples include anti-wrinkle agents and anti-inflammatory agents.
[0064]
Among the examples of anti-inflammatory agents are derivatives of liquorice, flavonoids, alpha-bisabolol, mannen wax, azulene, asiaticoside, lucogenin, escin, betulinic acid and derivatives thereof.
[0065]
Examples of anti-wrinkling agents are retinol, tocophenol, salicylates, and derivatives thereof.
[0066]
Several of these methods can be used for the manufacture of pantyhose or any textile supporter which is in direct contact with the skin, which is the subject of the present invention.
[0067]
Fixing with polymerized gels or resins containing the active ingredients (algae and drugs with synergistic action), adhesion and penetration of microcapsules, eg surface precipitation or absorption with a suitable surfactant.
[0068]
Cationic surfactants, nonionic surfactants, anionic surfactants, amphoteric surfactants, and their compounds have also been effectively utilized.
[0069]
Among the surfactants, the following may be mentioned:
[0070]
Nonionic surfactants: alkoxylates of alcohols and fatty acids or sorbitan fatty acids, polyoxypropylene and polyoxyethylene, alkyl polyglycosides; anionic surfactants: fatty acid soaps, sodium lauryl sulfate or lariur ether sulfate, alkylbenzene sulfonate , Mono and / or dialkyl phosphates, and the like;
[0071]
Amphoteric surfactants: dialkyl ammine oxides, various types of betaines, phospholipids, and natural ceramides.
[0072]
Among the surfactants, biomimetic phospholipids (Mona products, USA), which are cation-loaded glycero-phosphocholine substances, are preferred.
[0073]
In addition, the products that are the subject of the present invention are treated with substances having antiproliferative activity against various species of microorganisms, such as, for example, alkyls other than p-hydroxybenzoic acid, dantoine, Use a range of components of paraben, imidazolidinyl urea, sodium dehydroacetate, benzyl alcohol, and quaternary ammonium ions, and use inorganic or mixed substances such as components containing iodine and mercury.
[0074]
The sun filter may be mixed with a softening bath and activators such as PABA, derivatives of benzophenone, and cinamate in amounts depending on the degree of UV protection desired.
[0075]
Examples of typologies, stockings and pantyhose, and compositions using extracts of Urbalactus, extracts of green algae and extracts of German iris.
BEST MODE FOR CARRYING OUT THE INVENTION
[0076]
The accompanying drawings are given by way of example and do not limit the invention. The drawings only show embodiments of the present invention and are intended to make the invention easier to understand.
[0077]
FIG. 1 is a schematic drawing, which shows a circulation path that allows the anchoring or penetration of stockings or pantyhose or any textile supporter that is in direct contact with the skin.
[0078]
In this figure, a container 1 is composed of a phospholipid (phospholipid GLA (sodium borageamidopropyl PG dimonium chloride phosphate) and phospholipid PTC (cocamidopropyl PG dimonium chloride phosphate)), an active ingredient, and a softening agent. And is connected via tubing 2 to a larger container 3 which is a stocking or pantyhose or fixing and permeating container which includes any textile supporter 4 which comes into direct contact with the skin. The lattice 5 closes the container 3 at its upper part. A pipe 6 connects the container 3 to the container 1. The circuit is thus a closed circuit with a continuous flow.
[Brief description of the drawings]
[0079]
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic diagram illustrating a circuit that allows the anchoring or penetration of stockings or pantyhose or any textile supporter in direct contact with the skin.
[Explanation of symbols]
[0080]
DESCRIPTION OF SYMBOLS 1 Container 2 Piping 3 Fixing and penetrating container 4 Stocker or pantyhose or supporter of any textile which comes in direct contact with skin 5 Grid 6 Piping
Claims (9)
該製造方法が、染色の段階の後、柔軟化のプロセスの時に、従来の柔軟化用の浴に、バイオミメティックスのリン脂質の化合物を混ぜることで作用すること。
バイオミメティックスのリン脂質成分の化合物が、
A)浴の0.5%のリン脂質GLA(ボラージアミドプロピルPGジモニウムクロリドリン酸ナトリウム)、
B)浴の1.5%のリン脂質PTC(コカミドプロピルPGジモニウムクロリドリン酸)であること。
このリン脂質成分の化合物が、静電プロセスによって有効成分の「定着」あるいは浸透を促進させることを第一の働きとし、また細菌叢を制御する抗菌剤であることを第二の働きとすること。
これらの二つのリン脂質成分に、有効成分を含む天然物質が、最大合計2.10%で添加され、柔軟化および浸透の段階が、35℃と37℃の間に含まれる温度で約35分継続すること。A method for producing a stocking or pantyhose according to claim 1 or any textile supporter that comes into direct contact with the skin, allowing the natural substance to be slowly released to penetrate, characterized in that: I do.
The method works by mixing the biomimetic phospholipid compound into a conventional softening bath during the softening process after the dyeing step.
The compound of the phospholipid component of biomimetic is
A) 0.5% phospholipid GLA (sodium borageamidopropyl PG dimonium chloride phosphate) in the bath,
B) 1.5% phospholipid PTC (cocamidopropyl PG dimonium chloride phosphate) in the bath.
The primary function of this phospholipid component compound is to promote "fixation" or penetration of the active ingredient by an electrostatic process, and the second function is to be an antibacterial agent that controls the bacterial flora. .
To these two phospholipid components, the natural substance containing the active ingredient is added up to a total of 2.10%, and the softening and infiltration steps take place at a temperature comprised between 35 ° C. and 37 ° C. for about 35 minutes. To continue.
a)0.7%から最大1.00%の海藻、
b)0.3%から最大0.5%のウルバラクツカ、
c)0.3%から最大0.5%のジャーマンアイリス、
d)0.1%の香りのエッセンス、
最大合計で2.1%であることを特徴とする、請求項5に記載の製造方法。Active ingredients or natural substances,
a) 0.7% up to 1.00% seaweed;
b) 0.3% to up to 0.5% of Wolbarakutka,
c) 0.3% up to 0.5% German iris;
d) 0.1% fragrance essence,
6. The method according to claim 5, wherein the maximum total is 2.1%.
e)0.25%から最大0.35%のチョウセンニンジン、
f)0.25%から最大0.35%のイチョウ、
g)0.25%から最大0.35%のチドメグサ属、
h)0.25%から最大0.35%の緑茶、
i)0.50%から最大0.70%のアロエ(アロエベラ)、
最大合計で2.10%であることを特徴とする、請求項5に記載の製造方法。The active ingredient is
e) 0.25% up to 0.35% ginseng;
f) Ginkgo from 0.25% up to 0.35%,
g) from 0.25% to a maximum of 0.35% P.
h) 0.25% up to 0.35% green tea;
i) Aloe (Aloe Vera) from 0.50% up to 0.70%,
6. The method according to claim 5, wherein the maximum total is 2.10%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MC2469A MC200036A1 (en) | 2001-08-03 | 2001-08-03 | Cosmetic anti-aging stockings and tights |
PCT/EP2002/006232 WO2003014459A1 (en) | 2001-08-03 | 2002-06-07 | Cosmetologic and anti-ageing stocking or tights impregnated with slow-release natural substances and method for making same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004538381A true JP2004538381A (en) | 2004-12-24 |
Family
ID=19738423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003519578A Pending JP2004538381A (en) | 2001-08-03 | 2002-06-07 | Cosmetic and anti-aging stockings or pantyhose impregnated with slowly released natural substances and methods of making the same |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050015854A1 (en) |
EP (1) | EP1412575A1 (en) |
JP (1) | JP2004538381A (en) |
KR (1) | KR20040022225A (en) |
CN (1) | CN1306101C (en) |
HK (1) | HK1070405A1 (en) |
MC (1) | MC200036A1 (en) |
RU (1) | RU2298055C2 (en) |
WO (1) | WO2003014459A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220063776A (en) * | 2020-11-09 | 2022-05-18 | (주)메디위너 | Knitted fabric for improving blood circulation with cosmetotextile |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040223942A1 (en) * | 2003-03-06 | 2004-11-11 | Kao Corporation | Skin aging-preventing or improving agent |
US20040241210A1 (en) * | 2003-05-28 | 2004-12-02 | Jenkel Kelli K. | Method for applying sunless tanning composition to the human body using a tight fitting garment as the applicator |
US7182948B2 (en) * | 2003-08-04 | 2007-02-27 | Ko Manufacturing, Inc. | Topical veterinary compositions and methods for the treatment and prevention of infection |
US20060210496A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Compositions for skin protection from ultraviolet damage |
US20060210688A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Dehydrated sports drink powder |
US7666448B2 (en) | 2005-03-18 | 2010-02-23 | Sakura Properties, Llc | Skin cleansing article |
US20060210697A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Infant formula composition |
US7749545B2 (en) * | 2005-03-18 | 2010-07-06 | Sakura Properties, Llc | Fucoidan compositions and methods for dietary and nutritional supplements |
US20060210692A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Baby food composition |
US7776365B2 (en) * | 2005-03-18 | 2010-08-17 | Sakura Properties, Llc | Article with skin protecting and moisturizing compound |
US20070020358A1 (en) * | 2005-03-18 | 2007-01-25 | Mower Thomas E | Sports drink concentrate |
US20060210515A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Hair growth formula |
ITTO20050788A1 (en) * | 2005-11-09 | 2007-05-10 | Sagitta Srl | PROCEDURE FOR THE TREATMENT OF FABRICS AND CLOTHING GARMENTS |
DE102006032223A1 (en) * | 2006-07-07 | 2007-07-12 | Paul Hartmann Ag | Compressive or support stockings for legs for venous leg ulcers have under-stocking and over-stocking with foot and shank regions to apply steady pressure |
AU2011227198A1 (en) * | 2010-03-17 | 2012-10-04 | Arbonne International Llc | Topical skin care composition |
CN102631362B (en) * | 2012-01-19 | 2013-04-24 | 中国人民解放军第二军医大学 | Application of isoflavone compound in terms of preparation of medicines for preventing and curing skin injury caused by ultraviolet rays |
US20160000696A1 (en) * | 2013-03-14 | 2016-01-07 | Avon Products, Inc. | Sargassum muticum extracts and methods of use |
WO2015140744A1 (en) | 2014-03-18 | 2015-09-24 | Barcelcom Têxteis, S.A. | Sleeve and device with graduated compression for the treatment and/or prevention of lymphoedemas |
CN104705805B (en) * | 2015-04-03 | 2016-06-29 | 浙江宝娜斯袜业有限公司 | A kind of beauty mask moisturizing panty hose and preparation method thereof |
TWI663987B (en) * | 2016-05-17 | 2019-07-01 | 大江生醫股份有限公司 | Method for producing functional bio-cellulose membrane and the produced mask thereof |
FR3052070B1 (en) * | 2016-06-06 | 2019-09-13 | Mirei International Ltd | ORAL SKIN CARE OF NATURAL ORIGIN PROTECTING AGAINST EXTERNAL AND REGULATORY ATTACK EFFECTS BY ACTIVATION OF GENE EXPRESSION OF EPIDERMAL GROWTH FACTORS (EGF) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991001801A1 (en) * | 1989-08-01 | 1991-02-21 | Kanebo, Ltd. | Microcapsule, treatment liquid containing microcapsules, and textile structure having microcapsules stuck thereto |
FR2655268B1 (en) * | 1989-12-06 | 1994-10-14 | Secma | USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS. |
US5508033A (en) * | 1989-12-06 | 1996-04-16 | Societe D'engrais Composes Mineraux Et Amendments | Utilization of algae extract for the preparation of pharmaceutical, cosmetic, food or agricultural compositions |
TW208055B (en) * | 1992-02-19 | 1993-06-21 | Idemitsu Petrochem Kk | |
JPH06509816A (en) * | 1992-06-16 | 1994-11-02 | フイルメニツヒ ソシエテ アノニム | Flavored composition |
FR2746641B1 (en) * | 1996-03-27 | 1998-06-05 | Oreal | USE OF AN EXTRACT OF AT LEAST ONE IRIDACEA IN THE TREATMENT OF WRINKLES |
-
2001
- 2001-08-03 MC MC2469A patent/MC200036A1/en unknown
-
2002
- 2002-06-07 JP JP2003519578A patent/JP2004538381A/en active Pending
- 2002-06-07 CN CNB028152697A patent/CN1306101C/en not_active Expired - Fee Related
- 2002-06-07 EP EP02740692A patent/EP1412575A1/en not_active Withdrawn
- 2002-06-07 WO PCT/EP2002/006232 patent/WO2003014459A1/en not_active Application Discontinuation
- 2002-06-07 US US10/485,560 patent/US20050015854A1/en not_active Abandoned
- 2002-06-07 KR KR10-2004-7001593A patent/KR20040022225A/en not_active Application Discontinuation
- 2002-06-07 RU RU2004106158/04A patent/RU2298055C2/en not_active IP Right Cessation
-
2005
- 2005-04-13 HK HK05103141A patent/HK1070405A1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220063776A (en) * | 2020-11-09 | 2022-05-18 | (주)메디위너 | Knitted fabric for improving blood circulation with cosmetotextile |
KR102453435B1 (en) * | 2020-11-09 | 2022-10-12 | (주)메디위너 | Knitted fabric for improving blood circulation with cosmetotextile |
Also Published As
Publication number | Publication date |
---|---|
RU2298055C2 (en) | 2007-04-27 |
HK1070405A1 (en) | 2005-06-17 |
WO2003014459A1 (en) | 2003-02-20 |
CN1306101C (en) | 2007-03-21 |
MC200036A1 (en) | 2002-07-02 |
EP1412575A1 (en) | 2004-04-28 |
WO2003014459A8 (en) | 2004-12-23 |
US20050015854A1 (en) | 2005-01-27 |
RU2004106158A (en) | 2005-07-27 |
CN1539037A (en) | 2004-10-20 |
KR20040022225A (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004538381A (en) | Cosmetic and anti-aging stockings or pantyhose impregnated with slowly released natural substances and methods of making the same | |
JP4082823B2 (en) | Phototoxicity inhibitor | |
JP2004035440A (en) | Drabness inhibitor and external preparation for improving skin | |
KR20140078277A (en) | Skin Cosmetic Composition | |
JP2001354570A (en) | Immunoactivating agent and cosmetic using the same | |
JP2004189663A (en) | Maillard reaction inhibitor | |
JP2003095913A (en) | Cosmetic composition or food and drink | |
JP2003183120A (en) | Active oxygen scavenger or cosmetic composition | |
JP2003012531A (en) | Collagenease activity inhibitor or cosmetic composition | |
JP2004123637A (en) | Hyaluronic acid production promoter | |
JP2003342184A (en) | Hyaluronidase activity inhibitor and cosmetic composition | |
JP4033808B2 (en) | Beauty / health material containing Himefuuro extract | |
JP2004238310A (en) | Cosmetic composition, drink or food | |
JP2002316937A (en) | Plant extract-containing anti-allergic agent | |
KR101921518B1 (en) | A cosmetic composition comprising fermented spirulina extract for antioxydant and skin winkle improvement | |
JP2003226613A (en) | Protease activity-promoting agent | |
JP2001233725A (en) | Cosmetic composition containing polyphenol compound derived from oenothera tetraptera | |
KR101073107B1 (en) | manufacturing method for cosmetics containing berry cocktail composition | |
KR101893012B1 (en) | Method for Manufacturing Soap Containing Fermented Medicinal Herbs Include Ginseng | |
KR101797526B1 (en) | Hair cosmetic composition containing an extract of Dendropanax morbifera ferment | |
KR20190061277A (en) | shampoo composition for prevent alopecia and growing of hair | |
JP2001081021A (en) | Cosmetic composition | |
KR20180082058A (en) | A cosmetic composition for skin desquamation comprising natural complex extract | |
JP2003095967A (en) | Anti-allergic medicine | |
JP4079908B2 (en) | Makeup pack |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050419 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070814 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081111 |